Literature DB >> 2893776

Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis.

Z M Li1, J L Cowell, M J Brennan, D L Burns, C R Manclark.   

Abstract

Monoclonal antibodies that specifically agglutinate strains of Bordetella pertussis having serotype 1 agglutinogen were uniquely reactive with the electrophoretically slow-migrating A form of lipooligosaccharide. These monoclonal antibodies should be useful for the structural analysis of B. pertussis lipooligosaccharide and for the establishment of a better-defined serogroup for Bordetella species.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2893776      PMCID： PMC259348          DOI： 10.1128/iai.56.3.699-702.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  15 in total

1.  Serological study of Bordetella pertussis and related species.

Authors:  G ELDERING; C HORNBECK; J BAKER
Journal:  J Bacteriol       Date:  1957-08       Impact factor: 3.490

2.  A novel type of endotoxin structure present in Bordetella pertussis. Isolation of two different polysaccharides bound to lipid A.

Authors:  A Le Dur; M Caroff; R Chaby; L Szabó
Journal:  Eur J Biochem       Date:  1978-03-15

3.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

Authors:  C M Tsai; C E Frasch
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

Review 4.  Production of monoclonal antibodies: strategy and tactics.

Authors:  S F de StGroth; D Scheidegger
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

5.  Detection and localization of a lectin on Actinomyces viscosus T14V by monoclonal antibodies.

Authors:  J O Cisar; E L Barsumian; S H Curl; A E Vatter; A L Sandberg; R P Siraganian
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

6.  Heterogeneity of molecular size and antigenic expression within lipooligosaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis.

Authors:  H Schneider; T L Hale; W D Zollinger; R C Seid; C A Hammack; J M Griffiss
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

7.  Structure of the terminal reducing heptasaccharide of polysaccharide 1 isolated from the Bordetella pertussis endotoxin.

Authors:  M Moreau; R Chaby; L Szabo
Journal:  J Bacteriol       Date:  1984-08       Impact factor: 3.490

8.  Isolation of two protein-free and chemically different lipopolysaccharides from Bordetella pertussis phenol-extracted endotoxin.

Authors:  A Le Dur; R Chaby; L Szabó
Journal:  J Bacteriol       Date:  1980-07       Impact factor: 3.490

9.  Two physically and serologically distinct lipopolysaccharide profiles in strains of Bordetella pertussis and their phenotype variants.

Authors:  M S Peppler
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

10.  Heterogeneity and variation among Neisseria meningitidis lipopolysaccharides.

Authors:  C M Tsai; R Boykins; C E Frasch
Journal:  J Bacteriol       Date:  1983-08       Impact factor: 3.490
View more
  16 in total

1.  Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis.

Authors:  D Martin; M S Peppler; B R Brodeur
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

2.  Isotype and antigen specificity of pertussis agglutinins following whole-cell pertussis vaccination and infection with Bordetella pertussis.

Authors:  C M Mink; C H O'Brien; S Wassilak; A Deforest; B D Meade
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

3.  Invasion of HeLa 229 cells by virulent Bordetella pertussis.

Authors:  C A Ewanowich; A R Melton; A A Weiss; R K Sherburne; M S Peppler
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

4.  Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genes.

Authors:  A A Weiss; A R Melton; K E Walker; C Andraos-Selim; J J Meidl
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

5.  Lethal infection by Bordetella pertussis mutants in the infant mouse model.

Authors:  A A Weiss; M S Goodwin
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

6.  Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies.

Authors:  Z M Li; M J Brennan; J L David; P H Carter; J L Cowell; C R Manclark
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

7.  Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis.

Authors:  M J Brennan; Z M Li; J L Cowell; M E Bisher; A C Steven; P Novotny; C R Manclark
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

8.  Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide.

Authors:  R D Shahin; J Hamel; M F Leef; B R Brodeur
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

9.  Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features.

Authors:  M Caroff; R Chaby; D Karibian; J Perry; C Deprun; L Szabó
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

10.  Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection.

Authors:  K Bromberg; G Tannis; P Steiner
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.